Avenue Therapeutics Inc. buy BiotechBee
Start price
22.07.24
/
50%
€3.28
Target price
30.06.26
€5.00
Performance (%)
-46.65%
End price
14.12.24
€1.75
Summary
This prediction ended on 14.12.24 with a price of €1.75. The BUY prediction by BiotechBee for Avenue Therapeutics Inc. performed very badly with a performance of -46.65%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Avenue Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -0.437% | -5.315% | 1.438% |
| iShares Nasdaq 100 | -0.194% | 3.078% | 18.683% |
| iShares Nikkei 225® | -0.951% | -5.884% | 27.860% |
| iShares S&P 500 | -0.420% | 0.922% | 13.173% |
According to BiotechBee what are the pros and cons of Avenue Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year